Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
C., Odutola, O
All relevant diagnostic, visit, and procedural codes for outcome identification are detailed in Supplementary Table 3
The oral GLP-1 market size in 2025 was US$ 6.81 billion, expected to grow to US$ 9.19 billion in 2026 and further to US$ 137.36 billion by 2035, backed by a robust CAGR of 35.05% between 2026 and 2035
Exenatide remains effective but is generally less potent in both glycemic and weight outcomes, which has limited its current use (Thomsen et al., 2025)
If the LES does not close tightly or if the pressure in the stomach becomes too high, the acidic contents can reflux or move backward into the esophagus
RESEARCH USE ONLY (RUO): This product is supplied strictly for laboratory research and development purposes only
